Premium Nahrungsergänzungsmittel | artgerecht

Fatty Acid Binding Protein (FABP) – Function and Role

Fatty acid binding proteins (FABPs) are small intracellular proteins that transport long-chain fatty acids and play a central role in cellular metabolism and lipid homeostasis.

Regular tips about health Regular tips about health

Things worth knowing about "Fatty Acid Binding Protein"

Fatty acid binding proteins (FABPs) are small intracellular proteins that transport long-chain fatty acids and play a central role in cellular metabolism and lipid homeostasis.

What Is a Fatty Acid Binding Protein?

Fatty acid binding proteins (FABPs) are a family of small, intracellular proteins with a molecular weight of approximately 14–15 kilodaltons. They are found in virtually all tissues of the human body and play essential roles in the transport and metabolism of long-chain fatty acids and other lipophilic (fat-soluble) molecules.

At least 12 different FABP types have been identified in humans. Each is named according to the tissue in which it is predominantly expressed. Key members include heart-type FABP (H-FABP or FABP3), liver-type FABP (L-FABP or FABP1), intestinal FABP (I-FABP or FABP2), and brain-type FABP (B-FABP or FABP7).

Biological Functions

FABPs fulfill a range of critical functions within cells:

Intracellular transport: FABPs shuttle free fatty acids from the cytoplasm to mitochondria (for energy production via beta-oxidation), to the nucleus (for gene regulation), and to the endoplasmic reticulum (for lipid synthesis).
Regulation of fatty acid metabolism: They modulate the uptake, intracellular transport, and utilization of fatty acids within the cell.
Protective function: By binding free fatty acids, FABPs prevent their potentially toxic effects on cellular membranes and organelles.
Signal transduction: Certain FABP types participate in the activation of nuclear receptors such as PPARs (peroxisome proliferator-activated receptors), thereby influencing gene expression.

Clinical Significance as Biomarkers

When cells are damaged, FABPs are rapidly released into the bloodstream, making them sensitive biomarkers for tissue injury. Their diagnostic role has been studied extensively in the following conditions:

Myocardial Infarction and Cardiac Damage

Heart-type FABP (H-FABP) rises in the blood within 1–3 hours of a heart attack (myocardial infarction) – earlier than the classical marker troponin. This makes it a valuable early indicator of acute cardiac injury and it is used clinically to support the diagnosis of acute coronary syndrome.

Kidney Disease

Urinary liver-type FABP (L-FABP) is a sensitive marker for early kidney damage, particularly in chronic kidney disease, diabetic nephropathy, and acute kidney injury. It is under investigation as a potential surrogate marker for kidney function assessment.

Intestinal Injury

Intestinal FABP (I-FABP) is released when the intestinal mucosa is damaged, for example in intestinal ischemia, inflammatory bowel disease, or following major surgery. Elevated I-FABP levels in blood or urine indicate a disrupted intestinal barrier.

Neurological Conditions

Brain-type FABP (B-FABP) and neuronal FABP (FABP5) are released upon neuronal cell damage and are being explored as biomarkers in stroke, traumatic brain injury, and neurodegenerative diseases such as Alzheimer disease.

Role in Metabolic Disease

Alterations in FABP expression or function have been associated with several metabolic disorders:

Obesity: Certain FABP variants (e.g., FABP4) are associated with increased body fat and insulin resistance.
Type 2 diabetes: Elevated FABP4 levels in the blood are considered markers of insulin resistance and metabolic syndrome.
Atherosclerosis: FABPs are involved in lipid uptake by macrophages and may contribute to foam cell formation in arterial walls.
Cancer: Some FABP types are overexpressed in certain tumors and may facilitate fatty acid supply to rapidly proliferating cancer cells.

Diagnostic Testing

FABPs can be measured quantitatively in blood (serum or plasma) and urine using immunological assays such as ELISA (enzyme-linked immunosorbent assay). Reference values vary depending on the FABP type, measurement method, and laboratory. Elevated levels generally indicate damage to the corresponding tissue and must always be interpreted within the clinical context.

References

Furuhashi M, Hotamisligil GS. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nature Reviews Drug Discovery. 2008;7(6):489-503.
Pelsers MM, Hermens WT, Glatz JF. Fatty acid-binding proteins as plasma markers of tissue injury. Clinica Chimica Acta. 2005;352(1-2):15-35.
Storch J, Thumser AE. The fatty acid transport function of fatty acid-binding proteins. Biochimica et Biophysica Acta. 2000;1486(1):28-44.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.